Tenax Therapeutics (TENX) Enterprise Value Growth (1y) (2011 - 2026)
Tenax Therapeutics (TENX) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.56% |
| Dec 31, 2025 | -2.86% |
| Sep 30, 2025 | -1.08% |
| Jun 30, 2025 | -1,023.85% |
| Mar 31, 2025 | -788.09% |
| Dec 31, 2024 | -868.66% |
| Sep 30, 2024 | -782.41% |
| Jun 30, 2024 | 29.94% |
| Mar 31, 2024 | 12.94% |
| Dec 31, 2023 | -361.02% |
| Sep 30, 2023 | -192.69% |
| Jun 30, 2023 | -85.27% |
| Mar 31, 2023 | -402.49% |
| Dec 31, 2022 | 61.96% |
| Sep 30, 2022 | 54.44% |
| Jun 30, 2022 | -231.25% |
| Mar 31, 2022 | 28.85% |
| Dec 31, 2021 | 16.82% |
| Sep 30, 2021 | 4.07% |
| Jun 30, 2021 | 52.07% |